keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
LXW7 TFA, a cyclic peptide containing Arg-Gly-Asp (RGD), is an integrin αvβ3 inhibitor with an anti-inflammatory effect. LXW7 has a high binding affinity to αvβ3 integrin (IC50: 0.68 μM). It increases the phosphorylation of VEGFR-2 and activation of ERK1/2.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 mg | Inquiry | Inquiry | |
500 mg | Inquiry | Inquiry |
Description | LXW7 TFA, a cyclic peptide containing Arg-Gly-Asp (RGD), is an integrin αvβ3 inhibitor with an anti-inflammatory effect. LXW7 has a high binding affinity to αvβ3 integrin (IC50: 0.68 μM). It increases the phosphorylation of VEGFR-2 and activation of ERK1/2. |
Targets&IC50 | αvβ3 integrin:0.68 μM |
Synonyms | LXW7 TFA |
Molecular Weight | 934.92 |
Formula | C31H49F3N12O14S2 |
CAS No. | TP2148 |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
LXW7 TFA (1313004-77-1 free base) TP2148 Cytoskeletal Signaling Integrin LXW7 TFA (1313004771 free base) 1313004-77-1 free base 1313004-77-1 LXW7 TFA LXW-7 TFA (1313004-77-1 free base) LXW7 TFA (1313004 77 1 free base) inhibitor inhibit